A pathology report is the document a pathologist writes after examining tissue or fluid under a microscope to diagnose disease. For asbestos-related cancer, it confirms whether mesothelioma or lung cancer is present, describes the cell type, and records the tests used. It's usually the definitive record that establishes the diagnosis.
Origin
Pathology, from the Greek pathos, "suffering," and logia, "study," is the medical field that diagnoses disease by examining tissues and cells. The formal written report became standard as microscopy and, later, immunohistochemistry made tissue diagnosis increasingly precise.
Significance in Asbestos Context
For a patient, the pathology report is often the single most important document in both care and any claim, because it names the exact diagnosis and cell type that guide treatment and eligibility for trials, trusts, and lawsuits. For mesothelioma, it typically reports the subtype (epithelioid, sarcomatoid, or biphasic) and the immunohistochemical stains used to confirm it, which affects prognosis and treatment choices. The report may also note fiber findings if tissue analysis was done. Get a full copy, make sure the subtype and confirmatory tests are stated, and consider having a mesothelioma specialist review the slides, since this cancer is easily misdiagnosed.
Example Sentence
The pathology report confirmed epithelioid mesothelioma, listing the immunohistochemical stains used to rule out other cancers.
Related Terms
Immunohistochemistry, Epithelioid Mesothelioma, Biopsy, Fiber Burden Analysis, Second Opinion, Diagnosis
Notes
- Request a full copy of your pathology report and check that it states the specific cell type and subtype.
- Because mesothelioma is easily misdiagnosed, consider a slide review by a pathologist at a mesothelioma specialty center.
- Keep the report and, if possible, the tissue blocks; both matter for treatment, trust claims, and litigation.
In the research library
29 studies in our medical research library mention Pathology Report in the title or abstract. Among the most cited:
- BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology ReportG. Rossi, L. Righi, F. Barbisan, et al, 2024 · Journal of Personalized Medicine · cited 6 times
- The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplementsG.E. Goodman, M.D. Thornquist, J. Balmes, et al, 2004 · Journal of the National Cancer Institute · cited 290 times
- Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?E. Pulford, K. Huilgol, D. Moffat, et al, 2017 · Disease Markers · cited 49 times
- Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesotheliomaF.S. Alchami, R.L. Attanoos, A.R. Bamber, 2017 · Journal of Clinical Pathology · cited 26 times
- Asbestos and mesothelioma in South AfricaR.P. Abratt, D.A. Vorobiof, N. White, 2004 · Lung Cancer · cited 22 times
The journals that publish most on it: Curēus (3), Lung Cancer (2), Journal of Clinical Pathology (1).
Category: Diagnostic Tools & Biomarkers · All Lexicon terms A–Z
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.